Table 1.

Numbers of deaths (person years) and hazard ratios (95% confidence intervals) in patients treated with levodopa and selegiline (arm 2) and levodopa alone (arm 1)

Variable	Deaths (person years)		Hazard ratio (95% CI)
	Arm 1	Arm 2
Deaths before 1994 (previously reported)1	44 (1372.6)	76 (1500.5)	1.57 (1.09 to 2.30)
Deaths during additional follow up to end of September 1995	29 (336.6)	27 (334.3)	1.05 (0.60 to 1.86)
All deaths to end of September 1995	73 (1709.2)	103 (1834.8)	1.32 (0.98 to 1.79)
Patients randomised from arm 3	21 (368.0)	21 (280.5)	1.54 (0.83 to 2,87)
All patients including those rerandomised	94 (2077.2)	124 (2115.3)	1.33 (1.02 to 1.74)